PureTech Health (PRTC) Receivables (2019 - 2025)

PureTech Health (PRTC) has 7 years of Receivables data on file, last reported at $1.8 million in Q4 2025.

• Quarterly Receivables rose 15.51% year-over-year to $1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.8 million (up 15.51% YoY) and the FY2025 annual result came in at $1.8 million, up 15.51% from the prior year.
• Receivables climbed to $1.8 million in Q4 2025 per PRTC's latest filing, from $1.5 million in the prior quarter.
• Across five years, Receivables topped out at $3.6 million in Q4 2021 and bottomed at $450000.0 in Q4 2022.
• The 5-year median for Receivables is $1.5 million (2024), against an average of $1.6 million.
• The widest annual swing landed in 2022, when Receivables tumbled 87.46%; it then jumped 116.81% in 2024.
• Tracing PRTC's Receivables over 5 years: stood at $3.6 million in 2021, then plunged by 87.46% to $450000.0 in 2022, then jumped by 56.0% to $702000.0 in 2023, then jumped by 116.81% to $1.5 million in 2024, then climbed by 15.51% to $1.8 million in 2025.
• Per Business Quant, the three latest PRTC Receivables figures stand at $1.8 million (Q4 2025), $1.5 million (Q4 2024), and $702000.0 (Q4 2023).

Peer Comparison